Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry
Published in
Journal of Thrombosis and Thrombolysis, August 2023
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 August 2023.
All research outputs
#19,160,352
of 27,791,073 outputs
Outputs from Journal of Thrombosis and Thrombolysis
#882
of 1,252 outputs
Outputs of similar age
#211,880
of 371,121 outputs
Outputs of similar age from Journal of Thrombosis and Thrombolysis
#10
of 20 outputs
Altmetric has tracked 27,791,073 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,252 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one is in the 21st percentile – i.e., 21% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 371,121 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.